publication date: Feb. 3, 2017

In Brief Keith Flaherty named editor-in-chief of AACR journal Clinical Cancer Research

Keith Flaherty was named editor inchief of Clinical Cancer Research, one of eight peer-reviewed journals published by the American Association for Cancer Research.

Flaherty is director of the Termeer Center for Targeted Therapies and director of clinical research at the Massachusetts General Hospital Cancer Center, where he was named as the Richard Saltonstall Endowed Chair in Oncology, and a professor of medicine at Harvard Medical School. He began his tenure as editor-in-chief on Jan. 1.

“I am thrilled to take on this role at a time when the opportunities to advance science through methodologically rigorous clinical investigation are at an all-time high,” Flaherty said. “I benefit greatly from having served under Dr. Ken Anderson’s visionary leadership of the journal for the past six years as a senior editor.”

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. Manuscripts are reviewed for high standards of scientific merit; the journal accepts manuscripts that report results of novel, timely, and broadly significant research for publication.

“Dr. Flaherty is a world-renowned physician-scientist, and the American Association for Cancer Research is delighted to welcome him to the position of editor-in-chief of this important cancer research journal,” said AACR CEO … Continue reading Keith Flaherty named editor-in-chief of AACR journal Clinical Cancer Research

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.